3.8 Article

Modular Peptide Amphiphile Micelles Improving an Antibody-Mediated Immune Response to Group A Streptococcus

Journal

ACS BIOMATERIALS SCIENCE & ENGINEERING
Volume 3, Issue 2, Pages 144-152

Publisher

AMER CHEMICAL SOC
DOI: 10.1021/acsbiomaterials.6b00422

Keywords

Group A Streptococcus; J8 peptide; peptide amphiphile micelles; vaccine; biodistribution

Funding

  1. University of California, Berkeley
  2. University of Chicago
  3. University of Chicago Institute for Translational Medicine [CTSA UL1 TR000430]
  4. Pharmaceutics Division of the PhRMA Foundation [00052243]
  5. University of Missouri Research Board [3784]
  6. University of Missouri
  7. National Institute of Biomedical Imaging and Bioengineering of the National Institutes of Health [T32EB009412]

Ask authors/readers for more resources

Inducing a strong and specific immune response is the hallmark of a successful vaccine. Nanoparticles have emerged as promising vaccine delivery devices to discover and elicit immune responses, Fine-tuning a nanoparticle vaccine to create an immune response with specific antibody and other cellular responses is influenced by many factors such as shape, size, and composition. Peptide amphiphile micelles are a unique biomaterials platform that can function as a modular vaccine delivery system, enabling control over many of these important factors and delivering payloads more efficiently to draining lymph nodes. In this study, the modular properties of peptide amphiphile micelles are utilized to improve an immune response against a Group A Streptococcus B cell antigen (J8). The hydrophobic/hydrophilic interface of peptide amphiphile micelles enabled the precise entrapment of amphiphilic adjuvants which were found to not alter micelle formation or shape. These heterogeneous micelles significantly enhanced murine antibody responses when compared to animals vaccinated with nonadjuvanted micelles or soluble J8 peptide supplemented with a classical adjuvant. The heterogeneous micelle induced antibodies also showed cross-reactivity with wild-type Group A Streptococcus providing evidence that micelle-induced immune responses are capable of identifying their intended pathogenic targets.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

3.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available